Depression Clinical Trial
— MeDiVaOfficial title:
Mediterranean Diet and the Microbiota Gut Brain Axis- Does Diet Interact With the Function of Vagal Nerve in Major Depression?
The purpose of this study is to assess the efficacy of a Mediterranean diet on the function of the vagal nerve in patients with depression.
Status | Not yet recruiting |
Enrollment | 108 |
Est. completion date | September 30, 2029 |
Est. primary completion date | September 1, 2028 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 80 Years |
Eligibility | Inclusion Criteria: - legally competent persons aged 18-80 years - diagnosis of depression according to ICD-10 or DSM. Exclusion Criteria: - other neurologic or psychiatric disorders (epilepsy, brain tumor, head injury, head surgery, trauma) - drug or alcohol dependency - acute suicidality - heart disorders, disorders of the circulatory system - pregnancy and period of breastfeeding - severe mental disability, dementia (MMST<20) - autoimmune disorder, severe immunosuppression (Lupus, HIV, multiple sclerosis) - therapy with antibiotics in the last month - chronic laxative abuse - acute infectious diarrhea - GI surgeries (except appendectomy) - regular intake of probiotics, antibiotics and food supplements (1 month before and during the study) - food allergies or other food intolerances which are incompatible with a mediterranean diet - vegetarians, vegans |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Medical University of Graz |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in Vagal function | Vagal function measured by 24-hr ECG (logRSA, SDNN) | at study entry, after 7 days, after 4 weeks and after 3 months | |
Secondary | Change of C-reactive protein (CRP) | CRP will be measured from serum samples at the Institute of laboratory diagnostics (Cobas analyzer) | at study entry, after 7 days, after 4 weeks and after 3 months | |
Secondary | Change in Interleukine-6 | Interleukine-6 will be measured from serum samples at the Institute of laboratory diagnostics | at study entry, after 7 days, after 4 weeks and after 3 months | |
Secondary | Change in Oxytocin | measured from serum samples with ELISA | at study entry, after 7 days, after 4 weeks and after 3 months | |
Secondary | Change of Gut microbiome | 16S sequencing of a stool sample, gut microbiome data will be analyzed with QIIME2 with regard to diversity metrices (alpha-diversity, beta-diversity) and differential bacterial abundance. | at study entry, after 7 days, after 4 weeks and after 3 months | |
Secondary | Change of Body mass Index | Weight will be measured with a calibrated scale, height will be measured with a non-expandable measuring tape. BMI will be calculated according to the formula [kg/m2]. | at study entry, after 7 days, after 4 weeks and after 3 months | |
Secondary | Change in Hamilton Scale for Depression (HAMD) | Scale to rate severity of depressive symptoms; Scoring is based on the 17-item scale and scores of 0-7 are considered as being normal, 8-16 suggest mild depression, 17-23 moderate depression and scores over 24 are indicative of severe depression | at study entry, after 7 days, after 4 weeks and after 3 months | |
Secondary | Change in Beck Depression Inventory (BDI) | Self-rated scale to rate severity of depressive symptoms; Total score of 0-13 is considered minimal range, 14-19 is mild, 20-28 is moderate, and 29-63 is severe depression. | at study entry, after 7 days, after 4 weeks and after 3 months | |
Secondary | Change in Pittsburgh Sleep Quality Inventory (PSQI) | Questionnaire to assess sleep quality; global PSQI score is calculated by totaling the seven component scores, providing an overall score ranging from 0 to 21, where lower scores denote a healthier sleep quality. | at study entry, after 7 days, after 4 weeks and after 3 months | |
Secondary | Change in Adult Attachment Scale | Questionnaire to assess attachment style in adults; The scale consists of 18 items scored on a 5 point likert-type scale. It measures adult attachment styles named "Secure", "Anxious" and "Avoidant", defined as:
Secure = high scores on Close and Depend subscales, low score on Anxiety subscale Anxious = high score on Anxiety subscale, moderate scores on Close and Depend subscales Avoidant = low scores on Close, Depend, and Anxiety subscales |
at study entry, after 7 days, after 4 weeks and after 3 months | |
Secondary | Change in Wiener Ernährungsprotokoll | 24-hr food recall | at study entry, after 7 days, after 4 weeks and after 3 months | |
Secondary | Change in Mediterranean Diet Score | Questionnaire rating the diet according to Mediterranean dietary style; three categories of adherence to the Mediterranean diet can be calculated (=5, 6-9 and =10 points of the 14-item questionnaire) | at study entry, after 7 days, after 4 weeks and after 3 months | |
Secondary | Change in International Physical Acitivity Questionnaire | Questionnaire to rate physical activity; Physical activity is given in MET-minutes (METs are multiples of the resting metabolic rate) | at study entry, after 7 days, after 4 weeks and after 3 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05777044 -
The Effect of Hatha Yoga on Mental Health
|
N/A | |
Recruiting |
NCT04977232 -
Adjunctive Game Intervention for Anhedonia in MDD Patients
|
N/A | |
Recruiting |
NCT04680611 -
Severe Asthma, MepolizumaB and Affect: SAMBA Study
|
||
Recruiting |
NCT04043052 -
Mobile Technologies and Post-stroke Depression
|
N/A | |
Completed |
NCT04512768 -
Treating Comorbid Insomnia in Transdiagnostic Internet-Delivered Cognitive Behaviour Therapy
|
N/A | |
Recruiting |
NCT03207828 -
Testing Interventions for Patients With Fibromyalgia and Depression
|
N/A | |
Completed |
NCT04617015 -
Defining and Treating Depression-related Asthma
|
Early Phase 1 | |
Recruiting |
NCT06011681 -
The Rapid Diagnosis of MCI and Depression in Patients Ages 60 and Over
|
||
Completed |
NCT04476446 -
An Expanded Access Protocol for Esketamine Treatment in Participants With Treatment Resistant Depression (TRD) Who do Not Have Other Treatment Alternatives
|
Phase 3 | |
Recruiting |
NCT02783430 -
Evaluation of the Initial Prescription of Ketamine and Milnacipran in Depression in Patients With a Progressive Disease
|
Phase 2/Phase 3 | |
Recruiting |
NCT05563805 -
Exploring Virtual Reality Adventure Training Exergaming
|
N/A | |
Completed |
NCT04598165 -
Mobile WACh NEO: Mobile Solutions for Neonatal Health and Maternal Support
|
N/A | |
Completed |
NCT03457714 -
Guided Internet Delivered Cognitive-Behaviour Therapy for Persons With Spinal Cord Injury: A Feasibility Trial
|
||
Recruiting |
NCT05956912 -
Implementing Group Metacognitive Therapy in Cardiac Rehabilitation Services (PATHWAY-Beacons)
|
||
Completed |
NCT05588622 -
Meru Health Program for Cancer Patients With Depression and Anxiety
|
N/A | |
Recruiting |
NCT05234476 -
Behavioral Activation Plus Savoring for University Students
|
N/A | |
Active, not recruiting |
NCT05006976 -
A Naturalistic Trial of Nudging Clinicians in the Norwegian Sickness Absence Clinic. The NSAC Nudge Study
|
N/A | |
Enrolling by invitation |
NCT03276585 -
Night in Japan Home Sleep Monitoring Study
|
||
Completed |
NCT03167372 -
Pilot Comparison of N-of-1 Trials of Light Therapy
|
N/A | |
Terminated |
NCT03275571 -
HIV, Computerized Depression Therapy & Cognition
|
N/A |